000			02065 a2200541 4500
005			20250515165428.0
264		0	_c20090608
008			200906s 0 0 eng d
022			_a1535-7163
024	7		_a10.1158/1535-7163.MCT-08-0905 _2doi
040			_aNLM _beng _cNLM
100	1		_aSung, Bokyung
245	0	0	_aCurcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. _h[electronic resource]
260			_bMolecular cancer therapeutics _cApr 2009
300			_a959-70 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBlotting, Western
650	0	4	_aBoronic Acids _xadministration & dosage
650	0	4	_aBortezomib
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCurcumin _xadministration & dosage
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aDrug Synergism
650	0	4	_aHumans
650	0	4	_aImmunoenzyme Techniques
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aPyrazines _xadministration & dosage
650	0	4	_aSignal Transduction
650	0	4	_aThalidomide _xadministration & dosage
650	0	4	_aVascular Endothelial Growth Factor A _xmetabolism
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aKunnumakkara, Ajaikumar B
700	1		_aSethi, Gautam
700	1		_aAnand, Preetha
700	1		_aGuha, Sushovan
700	1		_aAggarwal, Bharat B
773	0		_tMolecular cancer therapeutics _gvol. 8 _gno. 4 _gp. 959-70
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-08-0905 _zAvailable from publisher's website
999			_c18804349 _d18804349